CN Stock MarketDetailed Quotes

688506 Sichuan Biokin Pharmaceutical

Watchlist
  • 196.63
  • -2.87-1.44%
Market Closed Dec 20 15:00 CST
78.85BMarket Cap20.75P/E (TTM)

Sichuan Biokin Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
1,399.22%5.66B
1,685.19%5.55B
4,325.45%5.46B
-20.11%561.87M
-21.37%377.7M
2.06%311.04M
1.74%123.43M
-11.73%703.28M
-21.75%480.34M
-27.97%304.76M
Operating revenue
1,399.22%5.66B
1,685.19%5.55B
4,325.45%5.46B
-20.11%561.87M
-21.37%377.7M
2.06%311.04M
1.74%123.43M
-11.73%703.28M
-21.75%480.34M
-27.97%304.76M
Total operating cost
44.60%1.36B
15.71%759.99M
29.87%386.89M
31.36%1.37B
26.45%943.85M
43.32%656.84M
65.18%297.91M
8.26%1.05B
7.13%746.41M
458.3M
Operating cost
21.07%175.79M
-0.81%111.4M
25.75%58.92M
-1.48%229.28M
-4.02%145.2M
29.79%112.3M
56.72%46.85M
17.71%232.74M
6.43%151.29M
-4.31%86.53M
Operating tax surcharges
45.60%7.89M
28.78%6.2M
127.81%3.25M
-23.34%10.48M
-40.62%5.42M
-12.38%4.81M
-36.67%1.43M
-3.29%13.67M
-16.98%9.12M
--5.49M
Operating expense
-13.17%156.05M
-24.07%106.99M
0.54%58.03M
-22.54%251.19M
-20.83%179.72M
-3.14%140.89M
4.98%57.72M
-17.12%324.3M
-25.58%227.01M
--145.46M
Administration expense
32.73%117.35M
28.63%71.29M
1.14%27.18M
48.26%116.7M
47.97%88.41M
46.16%55.42M
48.70%26.87M
3.35%78.71M
8.07%59.75M
--37.92M
Financial expense
-256.79%-23.99M
-860.43%-80.41M
-251.96%-9.26M
-5.70%20.76M
-2.20%15.3M
9.24%10.57M
40.32%6.09M
154.18%22.02M
168.15%15.65M
--9.68M
-Interest expense (Financial expense)
50.32%27.8M
32.82%16.65M
12.14%7.14M
9.78%24.68M
15.42%18.49M
25.85%12.53M
42.72%6.37M
158.64%22.48M
179.95%16.02M
--9.96M
-Interest Income (Financial expense)
-2,876.62%-130.18M
-2,905.23%-84.94M
-3,673.16%-21.01M
-643.96%-5.7M
-660.04%-4.37M
-631.01%-2.83M
-161.13%-556.88K
-61.45%-766.6K
-140.94%-575.4K
---386.63K
Research and development
82.76%931.7M
63.61%544.53M
56.52%248.77M
98.98%746.23M
79.77%509.8M
92.14%332.83M
124.47%158.94M
34.61%375.02M
59.82%283.59M
53.69%173.23M
Credit Impairment Loss
-76.27%1.48M
-43.49%968.47K
-115.45%-263.11K
183.82%6.44M
313.08%6.22M
221.57%1.71M
408.63%1.7M
-356.32%-7.69M
-208.23%-2.92M
---1.41M
Asset Impairment Loss
-23.55%-11.9M
-50.69%-9.22M
-23.87%-5.86M
-161.45%-12.98M
-145.14%-9.63M
-146.81%-6.12M
-374.12%-4.73M
12.44%-4.96M
-13.62%-3.93M
---2.48M
Other net revenue
Fair value change income
--11.44M
--13.56M
----
----
----
----
----
----
----
----
Invest income
493,205.27%19.23M
----
----
--3.9K
--3.9K
--3.9K
--3.9K
----
----
----
Asset deal income
----
----
----
853.26%146.39K
853.26%146.39K
853.26%146.39K
853.26%146.39K
-308.89%-19.43K
-308.89%-19.43K
---19.43K
Other revenue
-9.66%31.75M
345.67%30.28M
233.64%4.21M
-27.01%49.79M
49.71%35.15M
-66.07%6.79M
-93.14%1.26M
0.44%68.21M
-59.35%23.48M
--20.02M
Operating profit
914.18%4.35B
1,506.63%4.83B
2,981.04%5.07B
-167.48%-769.38M
-114.17%-534.25M
-149.76%-343.25M
-326.22%-176.09M
-183.49%-287.63M
-996.27%-249.46M
-418.56%-137.43M
Add:Non operating Income
-75.59%558.29K
-97.65%53.38K
-98.32%17.93K
3,461.65%2.3M
4,523.39%2.29M
4,820.73%2.27M
2,852.26%1.07M
-57.25%64.62K
-57.98%49.48K
--46.11K
Less:Non operating expense
-62.26%652.37K
2.88%639.25K
-63.18%145.65K
28.89%1.94M
25.07%1.73M
-53.09%621.36K
-63.66%395.53K
-51.90%1.5M
-50.70%1.38M
--1.32M
Total profit
915.01%4.35B
1,513.24%4.83B
2,991.97%5.07B
-166.03%-769.01M
-112.81%-533.7M
-146.27%-341.61M
-314.05%-175.42M
-176.79%-289.07M
-885.76%-250.79M
-379.09%-138.71M
Less:Income tax cost
1,629.45%284.32M
1,314.64%161.39M
891.75%68.04M
271.57%11.49M
-132.85%-18.59M
-1,210.80%-13.29M
-367.30%-8.59M
-50.60%-6.69M
-229.45%-7.98M
---1.01M
Net profit
889.23%4.07B
1,521.28%4.67B
3,100.16%5.01B
-176.40%-780.5M
-112.15%-515.11M
-138.43%-328.32M
-265.99%-166.83M
-182.40%-282.38M
-954.86%-242.81M
-486.36%-137.7M
Net profit from continuing operation
889.23%4.07B
1,521.28%4.67B
3,100.16%5.01B
-176.40%-780.5M
-112.15%-515.11M
-138.43%-328.32M
-265.99%-166.83M
-182.40%-282.38M
-954.86%-242.81M
---137.7M
Net profit of parent company owners
889.23%4.07B
1,521.28%4.67B
3,100.16%5.01B
-176.40%-780.5M
-112.15%-515.11M
-138.43%-328.32M
-265.99%-166.83M
-182.40%-282.38M
-954.86%-242.81M
-486.36%-137.7M
Earning per share
Basic earning per share
892.19%10.14
1,519.51%11.64
3,071.43%12.48
-150.00%-1.95
-91.04%-1.28
-115.79%-0.82
-223.08%-0.42
-178.57%-0.78
-1,016.67%-0.67
---0.38
Diluted earning per share
892.19%10.14
1,519.51%11.64
3,071.43%12.48
-150.00%-1.95
-91.04%-1.28
-115.79%-0.82
-223.08%-0.42
-178.57%-0.78
-1,016.67%-0.67
---0.38
Other composite income
747.31%15.59M
395.52%7.86M
56.28%-1.45M
-4,972.93%-1.67M
-183.46%-2.41M
-463.35%-2.66M
-4,383.76%-3.31M
110.16%34.22K
2,305.20%2.89M
731.66K
Other composite income of parent company owners
747.31%15.59M
----
56.28%-1.45M
-4,972.93%-1.67M
-183.46%-2.41M
----
-4,383.76%-3.31M
110.16%34.22K
2,305.20%2.89M
--731.66K
Total composite income
888.57%4.08B
1,512.24%4.67B
3,040.95%5B
-177.03%-782.17M
-115.70%-517.51M
-141.65%-330.98M
-273.89%-170.14M
-181.42%-282.34M
-947.78%-239.92M
-136.97M
Total composite income of parent company owners
888.57%4.08B
1,512.24%4.67B
3,040.95%5B
-177.03%-782.17M
-115.70%-517.51M
-141.65%-330.98M
-273.89%-170.14M
-181.42%-282.34M
-947.78%-239.92M
---136.97M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
--
--
--
Auditor
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024 (Q6)Jun 30, 2024 (Q3)Mar 31, 2024 (FY)Dec 31, 2023 (Q9)Sep 30, 2023 (Q6)Jun 30, 2023 (Q3)Mar 31, 2023 (FY)Dec 31, 2022 (Q9)Sep 30, 2022 (Q6)Jun 30, 2022
Total operating revenue 1,399.22%5.66B 1,685.19%5.55B 4,325.45%5.46B -20.11%561.87M -21.37%377.7M 2.06%311.04M 1.74%123.43M -11.73%703.28M -21.75%480.34M -27.97%304.76M
Operating revenue 1,399.22%5.66B 1,685.19%5.55B 4,325.45%5.46B -20.11%561.87M -21.37%377.7M 2.06%311.04M 1.74%123.43M -11.73%703.28M -21.75%480.34M -27.97%304.76M
Total operating cost 44.60%1.36B 15.71%759.99M 29.87%386.89M 31.36%1.37B 26.45%943.85M 43.32%656.84M 65.18%297.91M 8.26%1.05B 7.13%746.41M 458.3M
Operating cost 21.07%175.79M -0.81%111.4M 25.75%58.92M -1.48%229.28M -4.02%145.2M 29.79%112.3M 56.72%46.85M 17.71%232.74M 6.43%151.29M -4.31%86.53M
Operating tax surcharges 45.60%7.89M 28.78%6.2M 127.81%3.25M -23.34%10.48M -40.62%5.42M -12.38%4.81M -36.67%1.43M -3.29%13.67M -16.98%9.12M --5.49M
Operating expense -13.17%156.05M -24.07%106.99M 0.54%58.03M -22.54%251.19M -20.83%179.72M -3.14%140.89M 4.98%57.72M -17.12%324.3M -25.58%227.01M --145.46M
Administration expense 32.73%117.35M 28.63%71.29M 1.14%27.18M 48.26%116.7M 47.97%88.41M 46.16%55.42M 48.70%26.87M 3.35%78.71M 8.07%59.75M --37.92M
Financial expense -256.79%-23.99M -860.43%-80.41M -251.96%-9.26M -5.70%20.76M -2.20%15.3M 9.24%10.57M 40.32%6.09M 154.18%22.02M 168.15%15.65M --9.68M
-Interest expense (Financial expense) 50.32%27.8M 32.82%16.65M 12.14%7.14M 9.78%24.68M 15.42%18.49M 25.85%12.53M 42.72%6.37M 158.64%22.48M 179.95%16.02M --9.96M
-Interest Income (Financial expense) -2,876.62%-130.18M -2,905.23%-84.94M -3,673.16%-21.01M -643.96%-5.7M -660.04%-4.37M -631.01%-2.83M -161.13%-556.88K -61.45%-766.6K -140.94%-575.4K ---386.63K
Research and development 82.76%931.7M 63.61%544.53M 56.52%248.77M 98.98%746.23M 79.77%509.8M 92.14%332.83M 124.47%158.94M 34.61%375.02M 59.82%283.59M 53.69%173.23M
Credit Impairment Loss -76.27%1.48M -43.49%968.47K -115.45%-263.11K 183.82%6.44M 313.08%6.22M 221.57%1.71M 408.63%1.7M -356.32%-7.69M -208.23%-2.92M ---1.41M
Asset Impairment Loss -23.55%-11.9M -50.69%-9.22M -23.87%-5.86M -161.45%-12.98M -145.14%-9.63M -146.81%-6.12M -374.12%-4.73M 12.44%-4.96M -13.62%-3.93M ---2.48M
Other net revenue
Fair value change income --11.44M --13.56M ---- ---- ---- ---- ---- ---- ---- ----
Invest income 493,205.27%19.23M ---- ---- --3.9K --3.9K --3.9K --3.9K ---- ---- ----
Asset deal income ---- ---- ---- 853.26%146.39K 853.26%146.39K 853.26%146.39K 853.26%146.39K -308.89%-19.43K -308.89%-19.43K ---19.43K
Other revenue -9.66%31.75M 345.67%30.28M 233.64%4.21M -27.01%49.79M 49.71%35.15M -66.07%6.79M -93.14%1.26M 0.44%68.21M -59.35%23.48M --20.02M
Operating profit 914.18%4.35B 1,506.63%4.83B 2,981.04%5.07B -167.48%-769.38M -114.17%-534.25M -149.76%-343.25M -326.22%-176.09M -183.49%-287.63M -996.27%-249.46M -418.56%-137.43M
Add:Non operating Income -75.59%558.29K -97.65%53.38K -98.32%17.93K 3,461.65%2.3M 4,523.39%2.29M 4,820.73%2.27M 2,852.26%1.07M -57.25%64.62K -57.98%49.48K --46.11K
Less:Non operating expense -62.26%652.37K 2.88%639.25K -63.18%145.65K 28.89%1.94M 25.07%1.73M -53.09%621.36K -63.66%395.53K -51.90%1.5M -50.70%1.38M --1.32M
Total profit 915.01%4.35B 1,513.24%4.83B 2,991.97%5.07B -166.03%-769.01M -112.81%-533.7M -146.27%-341.61M -314.05%-175.42M -176.79%-289.07M -885.76%-250.79M -379.09%-138.71M
Less:Income tax cost 1,629.45%284.32M 1,314.64%161.39M 891.75%68.04M 271.57%11.49M -132.85%-18.59M -1,210.80%-13.29M -367.30%-8.59M -50.60%-6.69M -229.45%-7.98M ---1.01M
Net profit 889.23%4.07B 1,521.28%4.67B 3,100.16%5.01B -176.40%-780.5M -112.15%-515.11M -138.43%-328.32M -265.99%-166.83M -182.40%-282.38M -954.86%-242.81M -486.36%-137.7M
Net profit from continuing operation 889.23%4.07B 1,521.28%4.67B 3,100.16%5.01B -176.40%-780.5M -112.15%-515.11M -138.43%-328.32M -265.99%-166.83M -182.40%-282.38M -954.86%-242.81M ---137.7M
Net profit of parent company owners 889.23%4.07B 1,521.28%4.67B 3,100.16%5.01B -176.40%-780.5M -112.15%-515.11M -138.43%-328.32M -265.99%-166.83M -182.40%-282.38M -954.86%-242.81M -486.36%-137.7M
Earning per share
Basic earning per share 892.19%10.14 1,519.51%11.64 3,071.43%12.48 -150.00%-1.95 -91.04%-1.28 -115.79%-0.82 -223.08%-0.42 -178.57%-0.78 -1,016.67%-0.67 ---0.38
Diluted earning per share 892.19%10.14 1,519.51%11.64 3,071.43%12.48 -150.00%-1.95 -91.04%-1.28 -115.79%-0.82 -223.08%-0.42 -178.57%-0.78 -1,016.67%-0.67 ---0.38
Other composite income 747.31%15.59M 395.52%7.86M 56.28%-1.45M -4,972.93%-1.67M -183.46%-2.41M -463.35%-2.66M -4,383.76%-3.31M 110.16%34.22K 2,305.20%2.89M 731.66K
Other composite income of parent company owners 747.31%15.59M ---- 56.28%-1.45M -4,972.93%-1.67M -183.46%-2.41M ---- -4,383.76%-3.31M 110.16%34.22K 2,305.20%2.89M --731.66K
Total composite income 888.57%4.08B 1,512.24%4.67B 3,040.95%5B -177.03%-782.17M -115.70%-517.51M -141.65%-330.98M -273.89%-170.14M -181.42%-282.34M -947.78%-239.92M -136.97M
Total composite income of parent company owners 888.57%4.08B 1,512.24%4.67B 3,040.95%5B -177.03%-782.17M -115.70%-517.51M -141.65%-330.98M -273.89%-170.14M -181.42%-282.34M -947.78%-239.92M ---136.97M
Currency Unit CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY
Accounting Standards CAS (2007) CAS (2007) CAS (2007) CAS (2007) CAS (2007) CAS (2007) CAS (2007) CAS (2007) CAS (2007) CAS (2007)
Audit Opinions -- -- -- Unqualified opinion -- -- -- -- -- --
Auditor -- -- -- Lixin Certified Public Accountants (Special General Partnership) -- -- -- Lixin Certified Public Accountants (Special General Partnership) -- --

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data